Overview

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375

Status:
Unknown status
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the pharmacokinetics and safety/tolerability after oral administration of CKD-375 and D387 in healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical